Clinical Reminder Changes to Increase Smoking Cessation Treatment in Outpatient Psychiatry

Sponsor
NYU Langone Health (Other)
Overall Status
Completed
CT.gov ID
NCT04071795
Collaborator
National Institute on Drug Abuse (NIDA) (NIH)
140
1
2
13.6
10.3

Study Details

Study Description

Brief Summary

This study will use a scientifically robust, mixed-methods, two-arm cluster-randomized study design. Investigators will implement a tobacco use clinical reminder for outpatient psychiatrists practicing at the VA New York Harbor Healthcare System (N = 20). Half of the psychiatrists will receive a reminder that encourages the psychiatrist to offer cessation medications and referral to cessation counseling to patients interested in quitting (Opt-In Reminder). The other half will receive a clinical reminder that includes a standing NRT order and a referral to cessation counseling that will automatically generate unless the provider actively opts-out (Opt-Out Reminder). Prior to implementation of the reminders, psychiatrists in both arms will receive a one-hour training on tobacco treatment and individual education outreach to demonstrate the clinical reminder and answer questions (academic detailing).

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Opt-Out Reminder
  • Behavioral: Opt-In Reminder
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
140 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
2 arm cluster randomized study design2 arm cluster randomized study design
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Clinical Reminder Changes to Increase Smoking Cessation Treatment in Outpatient Psychiatry
Actual Study Start Date :
Jan 6, 2020
Actual Primary Completion Date :
Feb 24, 2021
Actual Study Completion Date :
Feb 24, 2021

Arms and Interventions

Arm Intervention/Treatment
Experimental: Opt Out

Training and Academic Detailing

Behavioral: Opt-Out Reminder
half will receive a clinical reminder that includes a standing NRT order and a referral to cessation counseling that will automatically generate unless the provider actively opts-out

Experimental: Opt In

Training and Academic Detailing

Behavioral: Opt-In Reminder
Half of the psychiatrists will receive a reminder that encourages the psychiatrist to offer cessation medications and referral to cessation counseling to patients interested in quitting

Outcome Measures

Primary Outcome Measures

  1. the percent of patients screened for smoking [3 Years]

  2. the percent of smokers prescribed a cessation medication [3 Years]

  3. the percent of smokers referred to counseling [3 Years]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 99 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Psychiatrists

  • Works in outpatient psychiatry at Manhattan or Brooklyn VA campus and has no plans to leave in the next 6 months

  • Patient Post-Visit Survey Population

  • Had a visit with a psychiatrist included in the study Current smoker

Exclusion Criteria:
  • Outpatient Psychiatrists:

  • None

  • Patient Post-Visit Survey Population:

  • Non-English speaking

Contacts and Locations

Locations

Site City State Country Postal Code
1 NYU Langone Health New York New York United States 10016

Sponsors and Collaborators

  • NYU Langone Health
  • National Institute on Drug Abuse (NIDA)

Investigators

  • Principal Investigator: Erin Rogers, DrPH, New York Langone Health

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
NYU Langone Health
ClinicalTrials.gov Identifier:
NCT04071795
Other Study ID Numbers:
  • 19-00813
First Posted:
Aug 28, 2019
Last Update Posted:
May 13, 2022
Last Verified:
May 1, 2022
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No

Study Results

No Results Posted as of May 13, 2022